Paris, Ile-de-France, France The leading representative office of defined Corporate Investor is situated in the Paris. The company was established in Europe in France.
Opposing the other organizations, this Cru00e9dit Lyonnais Private Equity works on 35 percentage points more the average amount of lead investments. The top activity for fund was in 2003. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2012. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Cru00e9dit Lyonnais Private Equity, startups are often financed by Sofinnova Partners, Societe Generale Asset Management, Sigma Designs. The meaningful sponsors for the fund in investment in the same round are Auriga Partners, Sofinnova Partners, HealthCap. In the next rounds fund is usually obtained by Intel Capital, Societe Generale Asset Management, Omnes Capital.
The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Biolipox, Emulation and Verification Engineering, Eptica. Among the most popular fund investment industries, there are Health Care, Broadcasting. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Sweden.
Related Funds
| Fund Name | Location |
| Alphabit Fund | California, San Francisco, United States |
| B37 Ventures | California, San Francisco, United States |
| Capitech | China, Shaanxi, Xian Shi |
| Cirrus Logic | Austin, Texas, United States |
| COFCO | Beijing, Beijing, China |
| Daekyo Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
| Executive Forum Angels | New York, New York, United States |
| Famous Group | - |
| FinTech Global | Japan, Tokyo |
| Green Innovations | Louisiana, New Orleans, United States |
| GT Healthcare Capital Partners | China, Hong Kong, Hong Kong Island |
| GWN Ltd | - |
| IR Japan | Japan, Tokyo |
| JGC Holdings Corporation | Japan, Kanagawa Prefecture, Yokohama |
| Jinyu Touzi | China, Songjiang, Songjiang District |
| Lanying Materials Trade | China, Jiangsu, Suzhou |
| Rally Capital | - |
| Rising Investments | Chengdu, China, Sichuan |
| Sonos | California, Santa Barbara, United States |
| Sony Interactive Entertainment | Chiyoda, Japan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Biolipox | $41M | 12 Jan 2005 | Sweden, Stockholm County, Sweden | ||
CareX SA | $32M | 08 Mar 2004 | France, Grand Est, France | ||
Esmertec AG | $27M | 13 Nov 2003 | Zurich, Switzerland | ||
Eptica | $2M | 07 Jul 2003 | Boulogne-Billancourt, Ile-de-France, France | ||
Orexo | $24M | 17 Jan 2003 | Uppsala County | ||
Biolipox | $21M | 15 Jan 2003 | Sweden, Stockholm County, Sweden | ||
Envivio | $14M | 22 May 2002 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Biolipox | $41M | 12 Jan 2005 | Sweden, Stockholm County, Sweden | ||
CareX SA | $32M | 08 Mar 2004 | France, Grand Est, France | ||
Esmertec AG | $27M | 13 Nov 2003 | Zurich, Switzerland | ||
Eptica | $2M | 07 Jul 2003 | Boulogne-Billancourt, Ile-de-France, France | ||
Orexo | $24M | 17 Jan 2003 | Uppsala County | ||
Biolipox | $21M | 15 Jan 2003 | Sweden, Stockholm County, Sweden | ||
Envivio | $14M | 22 May 2002 | San Francisco, California, United States |
